[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356656-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-356656-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","photodynamic-therapy-with-zinc-phthalocyanine-suppresses-immune-checkpoints-in-human-melanoma-cells","Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells","","Melanoma remains a major public health challenge due to rising incidence and frequent resistance to immune checkpoint inhibitors. This study evaluated how zinc phthalocyanine-based photodynamic therapy (ZnPc-PDT) affects immune checkpoint expression and immunogenic cell death in human melanoma cells. In silico analysis (TCGA-SKCM, GTEx via GEPIA) identified PD-L1, CD47, B7-H3, galectin-9, and HLA-G as key immune evasion regulators. ZnPc-PDT reduced several checkpoints in A375 and A2058 cells and triggered HMGB1 and Hsp70 upregulation across lines, with strongest changes in A2058. ZnPc-PDT showed phototoxicity with low IC50 values and suggests synergy with immunotherapies.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/photodynamic-therapy-with-zinc-phthalocyanine-suppresses-immune-checkpoints-in-human-melanoma-cells/356656/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/photodynamic-therapy-with-zinc-phthalocyanine-suppresses-immune-checkpoints-in-human-melanoma-cells/356656.png","ImageObject",300,407,{"name":42,"@type":43},"Jordan Avery","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main objective of this study?","Question",{"text":63,"@type":64},"To examine how zinc phthalocyanine-based photodynamic therapy affects immune checkpoint expression and immunogenic cell death markers in melanoma cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers identify key immune checkpoint molecules?",{"text":68,"@type":64},"They used in silico analysis with TCGA-SKCM and GTEx databases via the GEPIA platform to find dysregulated immune checkpoint molecules in melanoma.",{"name":70,"@type":61,"acceptedAnswer":71},"Which immune checkpoint markers were reduced after ZnPc-PDT treatment?",{"text":72,"@type":64},"ZnPc-PDT significantly reduced PD-L1 and CD47 in A375 and A2058 cells and induced downregulation of CD47 and HLA-G in SK-MEL-3.",{"name":74,"@type":61,"acceptedAnswer":75},"What immunogenic cell death markers were induced by ZnPc-PDT?",{"text":76,"@type":64},"ZnPc-PDT upregulated HMGB1 and Hsp70 across all tested melanoma cell lines, with the most pronounced increases in A2058 cells.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},356656,1790659772,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":116,"preview_page_count":33,"preview_urls":149},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Lasers in Medical Science (2026) 41:78  \n[https://doi.org/10.1007/s10103-026-04849-w](https://doi.org/10.1007/s10103-026-04849-w)  \nRESEARCH  \nPhotodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells  \nMohammad Amin Doustvandi1 · Masoumeh Hajizadeh1 · Fateme Mohammadnejad1 · Negin Karamali1 · Amir Hossein Yari1 · Shima Alizadeh Nobari1 · Behzad Baradaran1  \nReceived: 2 June 2025 / Accepted: 1 March 2026 © The Author(s) 2026  \nAbstract  \nMelanoma remains a major public health concern due to rising incidence and frequent resistance to immune checkpoint inhibitors. Photodynamic therapy (PDT) has emerged as a promising complementary strategy that exerts direct cytotoxic effects while simultaneously reshaping the tumor microenvironment to enhance immune recognition. This study aimed to examine the effects of PDT on immune checkpoint expression and immunogenic cell death markers in melanoma cells. We performed in silico analysis using TCGA-SKCM and GTEx databases via GEPIA platform to identify dysregulated immune checkpoint molecules in melanoma. We then evaluated zinc phthalocyanine-based PDT (ZnPc-PDT) effects on cell viability and immune checkpoint expression in three human melanoma cell lines (A375, A2058, SK-MEL-3) . Cytotoxicity was assessed by MTT assay, while qRT-PCR measured changes in PD-L1, CD47, B7-H3, galectin-9, and HLAG, HMGB1, and Hsp70 expression post-treatment. In silico analysis identified PD-L1, CD47, B7-H3, galectin-9, and HLA-G as critical immune evasion regulators. ZnPc-PDT significantly reduced these checkpoints in A375 and A2058 cells (p \u003C 0.0001 for PD-L1 and CD47; p \u003C 0.01–0.001 for others) . SK-MEL-3 showed limited response, with significant downregulation only for CD47 and HLA-G (p \u003C 0.01) . Importantly, ZnPc-PDT induced substantial upregulation of immunogenic cell death markers HMGB1 and Hsp70 across all cell lines, with the most pronounced increases observed in A2058 cells. ZnPc-PDT demonstrated potent phototoxic effects across all lines, with IC₅₀ values of 0.121, 0.109, and 0.032 µg/ml for A375, A2058, and SK-MEL-3, respectively. ZnPc-PDT acts as a multi-dimensional therapeutic strategy by simultaneously inducing tumor cell death and modulating immune checkpoint expression. Pronounced effects on PD-L1 and CD47 highlight potential synergy with current immunotherapies by converting melanoma cells into endogenous vaccines that can stimulate anti-tumor immune responses. Although in vivo validation is needed, our results support ZnPc-PDT as a complementary approach for treating immune-resistant melanomas and pave the way for future combination therapies.  \nKeywords photodynamic therapy · zinc phthalocyanine · immune checkpoint molecules · melanoma · immunomodulation  \n􀀍 Behzad Baradaran [behzad_im@yahoo.com](behzad_im@yahoo.com)  \nMohammad Amin Doustvandi  \n[m.amin.dostvandi@gmail.com](m.amin.dostvandi@gmail.com)[ ](m.amin.dostvandi@gmail.com)Masoumeh Hajizadeh[masoumeh.hajizadeh1000@gmail.com](masoumeh.hajizadeh1000@gmail.com)[ ](masoumeh.hajizadeh1000@gmail.com)Fateme Mohammadnejad [fatememohammadnejad@gmail.com](fatememohammadnejad@gmail.com)  \n1  \nNegin Karamali  \n[negiinkrmli@gmail.com](negiinkrmli@gmail.com)[ ](negiinkrmli@gmail.com)Amir Hossein Yari[amiryari777@gmail.com](amiryari777@gmail.com)[ ](amiryari777@gmail.com)Shima Alizadeh Nobari  \n[alizadeh.shima72@gmail.com](alizadeh.shima72@gmail.com)  \nImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n1 3  \nIntroduction  \nCutaneous tumors are the most common type of cancer worldwide, with approximately 1.5 million new cases diagnosed annually, including 325,000 cases of melanoma. The rising incidence of melanoma, particularly in fair-skinned populations, is strongly linked to ultraviolet (UV) exposure, which accounts for over 75% of cases. Despite this concerning trend, advancements in therapeutic strategies have led to a decline in melanoma-related mortality in the United Sta","cbCairqrCjvuFK4x","https://ap.wps.com/l/cbCairqrCjvuFK4x","pdf",1394128,12,"English","# Introduction\n## Background and melanoma epidemiology\n## Current treatment landscape and role of PDT\n## PDT-induced cell death and immune consequences\n## Interaction with the PD-1/PD-L1 axis","[{\"question\":\"What was the main objective of this study?\",\"answer\":\"To examine how zinc phthalocyanine-based photodynamic therapy affects immune checkpoint expression and immunogenic cell death markers in melanoma cells.\"},{\"question\":\"How did the researchers identify key immune checkpoint molecules?\",\"answer\":\"They used in silico analysis with TCGA-SKCM and GTEx databases via the GEPIA platform to find dysregulated immune checkpoint molecules in melanoma.\"},{\"question\":\"Which immune checkpoint markers were reduced after ZnPc-PDT treatment?\",\"answer\":\"ZnPc-PDT significantly reduced PD-L1 and CD47 in A375 and A2058 cells and induced downregulation of CD47 and HLA-G in SK-MEL-3.\"},{\"question\":\"What immunogenic cell death markers were induced by ZnPc-PDT?\",\"answer\":\"ZnPc-PDT upregulated HMGB1 and Hsp70 across all tested melanoma cell lines, with the most pronounced increases in A2058 cells.\"}]","Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells | PDF",1790126610,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93fb244569935b6c52354674fdb599a2.webp",983,1305,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea648266d11d034e839d6e661a2e06c8.webp",982,1304,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eec794cc0a86f737cc37876737ffc05.webp",981,1303,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3ea24a1df18c4ef945f18c72223bd2e.webp",980,1301]